{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:53:53Z","timestamp":1792551233418,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1038\/s41590-021-00966-6","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T16:03:24Z","timestamp":1626365004000},"page":"958-968","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Protective Zika vaccines engineered to eliminate enhancement of dengue infection via immunodominance switch"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8352-1327","authenticated-orcid":false,"given":"Lianpan","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingrui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2004-9250","authenticated-orcid":false,"given":"Jian","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuancheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0987-994X","authenticated-orcid":false,"given":"Huabing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kefang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianfeng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3768-0401","authenticated-orcid":false,"given":"Qihui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9358-4732","authenticated-orcid":false,"given":"Jianxun","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0502-3829","authenticated-orcid":false,"given":"Jinghua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3869-615X","authenticated-orcid":false,"given":"George F.","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,15]]},"reference":[{"key":"966_CR1","unstructured":"Knipe, D. M., Howley, P. M. (eds) Fields Virology 6th edn (Lippincott Williams & Wilkins Health, 2013)."},{"key":"966_CR2","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1016\/S0140-6736(17)31450-2","volume":"390","author":"D Baud","year":"2017","unstructured":"Baud, D., Gubler, D. J., Schaub, B., Lanteri, M. C. & Musso, D. An update on Zika virus infection. Lancet 390, 2099\u20132109 (2017).","journal-title":"Lancet"},{"key":"966_CR3","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1360\/N972016-00665","volume":"61","author":"Q Wang","year":"2016","unstructured":"Wang, Q. et al. Genetic and biological characterization of Zika virus from human cases imported through Shenzhen Port. Chin. Sci. Bull. 61, 2463\u20132474 (2016).","journal-title":"Chin. Sci. Bull."},{"key":"966_CR4","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1056\/NEJMoa1602412","volume":"375","author":"P Brasil","year":"2016","unstructured":"Brasil, P. et al. Zika virus infection in pregnant women in Rio de Janeiro. N. Engl. J. Med. 375, 2321\u20132334 (2016).","journal-title":"N. Engl. J. Med."},{"key":"966_CR5","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1056\/NEJMsr1604338","volume":"374","author":"SA Rasmussen","year":"2016","unstructured":"Rasmussen, S. A., Jamieson, D. J., Honein, M. A. & Petersen, L. R. Zika virus and birth defects\u2014reviewing the evidence for causality. N. Engl. J. Med. 374, 1981\u20131987 (2016).","journal-title":"N. Engl. J. Med."},{"key":"966_CR6","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1056\/NEJMc1605898","volume":"375","author":"AA van der Eijk","year":"2016","unstructured":"van der Eijk, A. A. et al. Miscarriage associated with Zika virus infection. N. Engl. J. Med. 375, 1002\u20131004 (2016).","journal-title":"N. Engl. J. Med."},{"key":"966_CR7","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","volume":"387","author":"VM Cao-Lormeau","year":"2016","unstructured":"Cao-Lormeau, V. M. et al. Guillain\u2013Barre Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 387, 1531\u20131539 (2016).","journal-title":"Lancet"},{"key":"966_CR8","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.chom.2017.01.004","volume":"21","author":"JJ Miner","year":"2017","unstructured":"Miner, J. J. & Diamond, M. S. Zika virus pathogenesis and tissue tropism. Cell Host Microbe 21, 134\u2013142 (2017).","journal-title":"Cell Host Microbe"},{"key":"966_CR9","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/j.cell.2016.11.016","volume":"167","author":"W Ma","year":"2016","unstructured":"Ma, W. et al. Zika virus causes testis damage and leads to male infertility in mice. Cell 167, 1511\u20131524.e10 (2016).","journal-title":"Cell"},{"key":"966_CR10","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nature20556","volume":"540","author":"J Govero","year":"2016","unstructured":"Govero, J. et al. Zika virus infection damages the testes in mice. Nature 540, 438\u2013442 (2016).","journal-title":"Nature"},{"key":"966_CR11","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/s41590-019-0477-z","volume":"20","author":"JL Slon-Campos","year":"2019","unstructured":"Slon-Campos, J. L. et al. A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection. Nat. Immunol. 20, 1291\u20131298 (2019).","journal-title":"Nat. Immunol."},{"key":"966_CR12","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.chom.2018.09.015","volume":"24","author":"AM Fowler","year":"2018","unstructured":"Fowler, A. M. et al. Maternally acquired Zika antibodies enhance dengue disease severity in mice. Cell Host Microbe 24, 743\u2013750.e5 (2018).","journal-title":"Cell Host Microbe"},{"key":"966_CR13","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.cell.2017.02.017","volume":"168","author":"JM Richner","year":"2017","unstructured":"Richner, J. M. et al. Modified mRNA vaccines protect against Zika virus infection. Cell 168, 1114\u20131125.e10 (2017).","journal-title":"Cell"},{"key":"966_CR14","doi-asserted-by":"publisher","first-page":"206","DOI":"10.15252\/embr.201745302","volume":"19","author":"FA Rey","year":"2018","unstructured":"Rey, F. A., Stiasny, K., Vaney, M. C., Dellarole, M. & Heinz, F. X. The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design. EMBO Rep. 19, 206\u2013224 (2018).","journal-title":"EMBO Rep."},{"key":"966_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1084\/jem.146.1.201","volume":"146","author":"SB Halstead","year":"1977","unstructured":"Halstead, S. B. & O\u2019Rourke, E. J. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J. Exp. Med. 146, 201\u2013217 (1977).","journal-title":"J. Exp. Med."},{"key":"966_CR16","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1126\/science.aan6836","volume":"358","author":"LC Katzelnick","year":"2017","unstructured":"Katzelnick, L. C. et al. Antibody-dependent enhancement of severe dengue disease in humans. Science 358, 929\u2013932 (2017).","journal-title":"Science"},{"key":"966_CR17","doi-asserted-by":"publisher","first-page":"6355","DOI":"10.1016\/j.vaccine.2017.09.089","volume":"35","author":"SB Halstead","year":"2017","unstructured":"Halstead, S. B. Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age. Vaccine 35, 6355\u20136358 (2017).","journal-title":"Vaccine"},{"key":"966_CR18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1056\/NEJMoa1800820","volume":"379","author":"S Sridhar","year":"2018","unstructured":"Sridhar, S. et al. Effect of dengue serostatus on dengue vaccine safety and efficacy. N. Engl. J. Med. 379, 327\u2013340 (2018).","journal-title":"N. Engl. J. Med."},{"key":"966_CR19","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.aaf8505","volume":"353","author":"K Stettler","year":"2016","unstructured":"Stettler, K. et al. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science 353, 823\u2013826 (2016).","journal-title":"Science"},{"key":"966_CR20","doi-asserted-by":"publisher","first-page":"10498","DOI":"10.1038\/s41598-017-10901-1","volume":"7","author":"J George","year":"2017","unstructured":"George, J. et al. Prior exposure to Zika virus significantly enhances peak Dengue-2 viremia in rhesus macaques. Sci. Rep. 7, 10498 (2017).","journal-title":"Sci. Rep."},{"key":"966_CR21","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1126\/science.abb6143","volume":"369","author":"LC Katzelnick","year":"2020","unstructured":"Katzelnick, L. C. et al. Zika virus infection enhances future risk of severe dengue disease. Science 369, 1123\u20131128 (2020).","journal-title":"Science"},{"key":"966_CR22","first-page":"605","volume":"18","author":"A York","year":"2020","unstructured":"York, A. Zika virus enhances dengue risk. Nat. Rev. Microbiol. 18, 605 (2020).","journal-title":"Nat. Rev. Microbiol."},{"key":"966_CR23","doi-asserted-by":"publisher","first-page":"eaan6809","DOI":"10.1126\/sciimmunol.aan6809","volume":"2","author":"TF Rogers","year":"2017","unstructured":"Rogers, T. F. et al. Zika virus activates de novo and cross-reactive memory B cell responses in dengue-experienced donors. Sci. Immunol. 2, eaan6809 (2017).","journal-title":"Sci. Immunol."},{"key":"966_CR24","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1126\/science.1185181","volume":"328","author":"W Dejnirattisai","year":"2010","unstructured":"Dejnirattisai, W. et al. Cross-reacting antibodies enhance dengue virus infection in humans. Science 328, 745\u2013748 (2010).","journal-title":"Science"},{"key":"966_CR25","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.chom.2010.08.007","volume":"8","author":"M Beltramello","year":"2010","unstructured":"Beltramello, M. et al. The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe 8, 271\u2013283 (2010).","journal-title":"Cell Host Microbe"},{"key":"966_CR26","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ni.3058","volume":"16","author":"W Dejnirattisai","year":"2015","unstructured":"Dejnirattisai, W. et al. A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nat. Immunol. 16, 170\u2013177 (2015).","journal-title":"Nat. Immunol."},{"key":"966_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/978-981-10-8456-0_7","volume":"88","author":"L Dai","year":"2018","unstructured":"Dai, L., Wang, Q., Song, H. & Gao, G. F. Zika virus envelope protein and antibody complexes. Subcell. Biochem. 88, 147\u2013168 (2018).","journal-title":"Subcell. Biochem."},{"key":"966_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nature18938","volume":"536","author":"G Barba-Spaeth","year":"2016","unstructured":"Barba-Spaeth, G. et al. Structural basis of potent Zika\u2013dengue virus antibody cross-neutralization. Nature 536, 48\u201353 (2016).","journal-title":"Nature"},{"key":"966_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature14130","volume":"520","author":"A Rouvinski","year":"2015","unstructured":"Rouvinski, A. et al. Recognition determinants of broadly neutralizing human antibodies against dengue viruses. Nature 520, 109\u2013113 (2015).","journal-title":"Nature"},{"key":"966_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.antiviral.2016.01.002","volume":"128","author":"G Fibriansah","year":"2016","unstructured":"Fibriansah, G. & Lok, S. M. The development of therapeutic antibodies against dengue virus. Antivir. Res. 128, 7\u201319 (2016).","journal-title":"Antivir. Res."},{"key":"966_CR31","doi-asserted-by":"publisher","first-page":"369ra179","DOI":"10.1126\/scitranslmed.aai8336","volume":"8","author":"Q Wang","year":"2016","unstructured":"Wang, Q. et al. Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus. Sci. Transl. Med. 8, 369ra179 (2016).","journal-title":"Sci. Transl. Med."},{"key":"966_CR32","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.cell.2016.07.020","volume":"166","author":"H Zhao","year":"2016","unstructured":"Zhao, H. et al. Structural basis of Zika virus-specific antibody protection. Cell 166, 1016\u20131027 (2016).","journal-title":"Cell"},{"key":"966_CR33","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41579-018-0039-7","volume":"16","author":"P Abbink","year":"2018","unstructured":"Abbink, P., Stephenson, K. E. & Barouch, D. H. Zika virus vaccines. Nat. Rev. Microbiol. 16, 594\u2013600 (2018).","journal-title":"Nat. Rev. Microbiol."},{"key":"966_CR34","doi-asserted-by":"crossref","first-page":"e01722-17","DOI":"10.1128\/JVI.01722-17","volume":"92","author":"K Xu","year":"2018","unstructured":"Xu, K. et al. Recombinant chimpanzee adenovirus vaccine AdC7-M\/E protects against Zika virus infection and testis damage. J. Virol. 92, e01722-17 (2018).","journal-title":"J. Virol."},{"key":"966_CR35","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.chom.2016.04.013","volume":"19","author":"L Dai","year":"2016","unstructured":"Dai, L. et al. Structures of the Zika virus envelope protein and its complex with a flavivirus broadly protective antibody. Cell Host Microbe 19, 696\u2013704 (2016).","journal-title":"Cell Host Microbe"},{"key":"966_CR36","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1038\/emboj.2009.245","volume":"28","author":"MV Cherrier","year":"2009","unstructured":"Cherrier, M. V. et al. Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody. EMBO J. 28, 3269\u20133276 (2009).","journal-title":"EMBO J."},{"key":"966_CR37","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/nature18952","volume":"536","author":"RA Larocca","year":"2016","unstructured":"Larocca, R. A. et al. Vaccine protection against Zika virus from Brazil. Nature 536, 474\u2013478 (2016).","journal-title":"Nature"},{"key":"966_CR38","doi-asserted-by":"publisher","first-page":"eaao4163","DOI":"10.1126\/scitranslmed.aao4163","volume":"9","author":"P Abbink","year":"2017","unstructured":"Abbink, P. et al. Durability and correlates of vaccine protection against Zika virus in rhesus monkeys. Sci. Transl. Med. 9, eaao4163 (2017).","journal-title":"Sci. Transl. Med."},{"key":"966_CR39","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1128\/JVI.01805-15","volume":"90","author":"SA Smith","year":"2016","unstructured":"Smith, S. A. et al. Dengue virus prM-specific human monoclonal antibodies with virus replication-enhancing properties recognize a single immunodominant antigenic site. J. Virol. 90, 780\u2013789 (2016).","journal-title":"J. Virol."},{"key":"966_CR40","doi-asserted-by":"publisher","first-page":"12562","DOI":"10.1128\/JVI.00871-13","volume":"87","author":"WY Tsai","year":"2013","unstructured":"Tsai, W. Y. et al. High-avidity and potently neutralizing cross-reactive human monoclonal antibodies derived from secondary dengue virus infection. J. Virol. 87, 12562\u201312575 (2013).","journal-title":"J. Virol."},{"key":"966_CR41","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.chom.2016.03.010","volume":"19","author":"HM Lazear","year":"2016","unstructured":"Lazear, H. M. et al. A mouse model of Zika virus pathogenesis. Cell Host Microbe 19, 720\u2013730 (2016).","journal-title":"Cell Host Microbe"},{"key":"966_CR42","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.chom.2007.03.002","volume":"1","author":"TC Pierson","year":"2007","unstructured":"Pierson, T. C. et al. The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection. Cell Host Microbe 1, 135\u2013145 (2007).","journal-title":"Cell Host Microbe"},{"key":"966_CR43","doi-asserted-by":"publisher","first-page":"13975","DOI":"10.1128\/JVI.78.24.13975-13986.2004","volume":"78","author":"WD Crill","year":"2004","unstructured":"Crill, W. D. & Chang, G. J. Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes. J. Virol. 78, 13975\u201313986 (2004).","journal-title":"J. Virol."},{"key":"966_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12896-015-0194-0","volume":"15","author":"KM Bennett","year":"2015","unstructured":"Bennett, K. M. et al. Hybrid flagellin as a T cell independent vaccine scaffold. BMC Biotechnol. 15, 71 (2015).","journal-title":"BMC Biotechnol."},{"key":"966_CR45","doi-asserted-by":"publisher","first-page":"e16059","DOI":"10.1371\/journal.pone.0016059","volume":"6","author":"YQ Deng","year":"2011","unstructured":"Deng, Y. Q. et al. A broadly flavivirus cross-neutralizing monoclonal antibody that recognizes a novel epitope within the fusion loop of E protein. PLoS ONE 6, e16059 (2011).","journal-title":"PLoS ONE"},{"key":"966_CR46","doi-asserted-by":"publisher","first-page":"12149","DOI":"10.1128\/JVI.01732-06","volume":"80","author":"T Oliphant","year":"2006","unstructured":"Oliphant, T. et al. Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein. J. Virol. 80, 12149\u201312159 (2006).","journal-title":"J. Virol."},{"key":"966_CR47","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.15585\/mmwr.mm6547e2","volume":"65","author":"V van der Linden","year":"2016","unstructured":"van der Linden, V. et al. Description of 13 infants born during October 2015\u2013January 2016 with congenital Zika virus infection without microcephaly at birth\u2014Brazil. MMWR Morb. Mortal. Wkly Rep. 65, 1343\u20131348 (2016).","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"966_CR48","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/ni.3849","volume":"18","author":"E Fernandez","year":"2017","unstructured":"Fernandez, E. et al. Human antibodies to the dengue virus E-dimer epitope have therapeutic activity against Zika virus infection. Nat. Immunol. 18, 1261\u20131269 (2017).","journal-title":"Nat. Immunol."},{"key":"966_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15411","volume":"8","author":"A Rouvinski","year":"2017","unstructured":"Rouvinski, A. et al. Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope. Nat. Commun. 8, 15411 (2017).","journal-title":"Nat. Commun."},{"key":"966_CR50","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3389\/fimmu.2012.00334","volume":"3","author":"WD Crill","year":"2012","unstructured":"Crill, W. D. et al. Sculpting humoral immunity through dengue vaccination to enhance protective immunity. Front. Immunol. 3, 334 (2012).","journal-title":"Front. Immunol."},{"key":"966_CR51","doi-asserted-by":"publisher","first-page":"10638","DOI":"10.1074\/jbc.RA119.007443","volume":"294","author":"C Yang","year":"2019","unstructured":"Yang, C. et al. Characterization of two engineered dimeric Zika virus envelope proteins as immunogens for neutralizing antibody selection and vaccine design. J. Biol. Chem. 294, 10638\u201310648 (2019).","journal-title":"J. Biol. Chem."},{"key":"966_CR52","doi-asserted-by":"publisher","first-page":"W34","DOI":"10.1093\/nar\/gkt382","volume":"41","author":"J Ye","year":"2013","unstructured":"Ye, J., Ma, N., Madden, T. L. & Ostell, J. M. IgBLAST: an immunoglobulin variable domain sequence analysis tool. Nucleic Acids Res. 41, W34\u2013W40 (2013).","journal-title":"Nucleic Acids Res."},{"key":"966_CR53","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","volume":"276","author":"Z Otwinowski","year":"1997","unstructured":"Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307\u2013326 (1997).","journal-title":"Methods Enzymol."},{"key":"966_CR54","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1107\/S0907444901012471","volume":"57","author":"RJ Read","year":"2001","unstructured":"Read, R. J. Pushing the boundaries of molecular replacement with maximum likelihood. Acta Crystallogr. D Biol. Crystallogr. 57, 1373\u20131382 (2001).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"966_CR55","doi-asserted-by":"crossref","unstructured":"Collaborative Computational Project, Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50, 760\u2013763 (1994).","DOI":"10.1107\/S0907444994003112"},{"key":"966_CR56","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"966_CR57","doi-asserted-by":"publisher","first-page":"161801","DOI":"10.1103\/PhysRevLett.105.161801","volume":"105","author":"G Aad","year":"2010","unstructured":"Aad, G. et al. Search for new particles in two-jet final states in 7\u2009TeV proton-proton collisions with the ATLAS detector at the LHC. Phys. Rev. Lett. 105, 161801 (2010).","journal-title":"Phys. Rev. Lett."},{"key":"966_CR58","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 66, 12\u201321 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"966_CR59","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-021-00966-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-021-00966-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-021-00966-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T22:48:57Z","timestamp":1733957337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-021-00966-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,15]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["966"],"URL":"https:\/\/doi.org\/10.1038\/s41590-021-00966-6","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,15]]},"assertion":[{"value":"24 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.F.G, L.D., J.Y., K.X., Y.H., Q.W., Q.H. and J.L. are listed as the coinventors for the pending patent for the ZIKV vaccines described in this study. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}